OLMESARTAN « New Drug Approvals

OLMESARTAN « New Drug Approvals:

'via Blog this'

Ondansetron « New Drug Approvals

Ondansetron « New Drug Approvals:

'via Blog this'

REMOGLIFLOZIN » All About Drugs

REMOGLIFLOZIN » All About Drugs:

'via Blog this'

LUSEOGLIFLOZIN » All About Drugs

LUSEOGLIFLOZIN » All About Drugs:

'via Blog this'

Empagliflozin « New Drug Approvals

Empagliflozin « New Drug Approvals:

'via Blog this'

Ipragliflozin « New Drug Approvals

Ipragliflozin « New Drug Approvals:

'via Blog this'

FDA Approves Anoro Ellipta to Treat Chronic Obstructive Pulmonary Disease

December 18, 2013 -- The U.S. Food and Drug Administration today approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).

COPD is a serious lung disease that makes breathing difficult and worsens over time. Symptoms can include chest tightness, chronic cough and excessive phlegm. Cigarette smoking is the leading cause of COPD. According to the National Heart, Lung, and Blood Institute, COPD is the third leading cause of death in the United States
read at
 http://www.drugs.com/newdrugs/fda-approves-anoro-ellipta-chronic-obstructive-pulmonary-3992.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+December+18%2C+2013